The independent source for health policy research, polling, and news.
Emily Kopp was a reporter for ϳԹ News until September 2018.
Showing 1 - 17 of 17
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws.
Kaiser Health News launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.
A little-noticed provision in President Donald Trump’s executive order on drug prices may offer a clue to why Big Pharma hasn’t opposed a bill that could bleed their balance sheets of millions of patients.
Documents examined by Kaiser Health News shed light on the workings of the Trump administration's “Drug Pricing and Innovation Working Group."
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics.
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
A plan to test the effectiveness of so-called “Frankenflies” is being closely watched by nearby Miami-Dade County as a possible way to combat the spread of Zika.
WikiLeaks documents show a cautious speaker who tried to avoid compromises on policy.
Efforts to control and track the mosquitoes that carry the Zika virus have been hampered by lack of resources.
As Miami-Dade doubles down on aerial spraying of the insecticide naled to combat the mosquitoes that spread Zika, experts question that approach.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF